American Justice Partnership

Opinions/Editorials on the Case for Legal Reform

 
 

 

Silicosis: Asbestosis Redux

by

Professor Lester Brickman

Benjamin N. Cardozo School of Law at Yeshiva University

 

As appeared in the Wall Street Journal

 

In the mid 1980s, court decisions dramatically enlarged insurance companies' liability for asbestos-related injury. At the same time, defendants and their insurers began to pay asbestos claims without demanding much in the way of proof of injury or liability. Plaintiffs' lawyers responded opportunistically. As a consequence, asbestosis litigation, which had previously focused on malignancies and other debilitating injuries, shifted radically from the traditional model of an injured person seeking a lawyer, to an entrepreneurial model that reversed the process. Lawyers spent millions to sponsor mass screenings of upwards of 750,000 industrial and construction workers. Of the 850,000 asbestos claimants that have so far brought suit against over 8,400 different defendants, about 600,000 have been recruited by these mass screenings.

 

Most of these 600,000 plaintiffs claim a mild form of asbestosis (a scarring of lung tissue), or other nonmalignant condition, but suffer no symptoms or lung impairment. They have no asbestos-related injury recognized by medical science and no significant probability of manifesting an asbestos-related malignancy in the future. Nevertheless, lawyers charging 40% contingency fees have extracted tens of billions of dollars in settlements, after hiring a comparative handful of doctors who consistently read X-rays and "diagnose" disease in 60% to 80% of those screened.

 

According to medical science, however, asbestosis is a "disappearing disease" and only 2%-4% of claimants now generated by screenings have an actual nonmalignant condition resulting from asbestos exposure. This had led me to previously conclude that the X-ray readings and "diagnoses" of these litigation doctors were not a product of good faith medical judgment but rather a function of the millions of dollars a year that the lawyers pay these doctors for their litigation services. Overwhelming evidence in support of these conclusions about asbestos litigation has recently come to light in the not-unrelated litigation based on exposure to silica or sand.

 

Silicosis, like asbestosis, is a scarring of the lungs but is caused by the inhalation of large quantities of fine sand dust. Like asbestosis, silicosis, once a scourge, is a disappearing disease because of strict government regulations and employer practices. Deaths attributable to silicosis have dropped over 80% in the past 30 years. But beginning in 2002, claim filings in state courts, mostly in Mississippi, reached "epidemic" proportions.

 

The reasons for the "epidemic" are that key states began to adopt comprehensive asbestos litigation reform and Congress took up consideration of a fund (paid for by defendants and insurance companies) to pay claims as a way of taking asbestos litigation out of the tort system. Worried about the future of their enterprise, lawyers, doctors and screening companies abruptly shifted gears from ginning up claims based on asbestosis to claims based on silicosis. As one lawyer acknowledged, "why reinvent the wheel."

 

All this became clear when 10,000 of the 35,000 pending silica claims were centralized into a federal multi-district litigation (MDL), presided over by U.S. District Court Judge Janis Jack, a Clinton appointee. During the course of the MDL, one of the doctors who diagnosed 3,617 of the 10,000 plaintiffs as having silicosis recanted all of his diagnoses, provoking Judge Jack to observe that "it's clear this . . . diagnosing] business is fraudulent." She went on to issue an unprecedented order that allowed defendants to cross examine every doctor in her presence who had provided a silicosis diagnosis as well as the owners of the screening companies.

 

It turns out that 6,000 of the plaintiffs had previously filed asbestosis claims. Nevertheless, pulmonary experts testifying at a U.S. Senate hearing stated that while it was theoretically possible to have both asbestosis and silicosis, they had never seen a single dual disease case in the course of their extensive practices. Moreover, many of the X-ray readings on which the silicosis diagnoses were based were by the same doctors who had previously read the X-rays as "consistent with asbestosis"-but who had never mentioned silicosis.

 

Judge Jack concluded that "the lawyers, doctors and screening companies" were "all willing participants" in a "scheme [that] manufactured [diagnoses] for money"-the equivalent of a finding of pervasive fraud.

 

Judge Jack did what no judge had ever done before with regard to claims generated by mass screenings: she permitted extensive discovery of the doctors and screening companies involved. If the same level of discovery were to be permitted in asbestos lawsuits, I have no doubt that it would elicit similar information about the mass screenings-suits that have resulted in billions of dollars in settlements.

 

The same screening companies, X-ray readers and diagnosing doctors excoriated by Judge Jack have been a hallmark of asbestos litigation for almost 20 years. As Judge Jack observed, the "evidence of the unreliability of the [X-ray] reads performed for this MDL is matched by evidence of the unreliability of [X-ray] reads in asbestos litigation."

 

Sitting in Judge Jack's courtroom during the cross examinations was an assistant U.S. Attorney from the Southern District of New York. {note: David Siegal} He was there because a federal grand jury had been convened in mid 2004 to consider possible criminal charges arising from claims of exposure to silica and asbestos and the use of witness-coaching techniques to implant false memories about product exposure.

 

Asbestos litigation, meanwhile, has led to the loss of 500,000 jobs that would have been created but for the diversion of capital due to over 70 asbestos-related bankruptcies. Plaintiff lawyers have exercised undue influence over the asbestos bankruptcy process, essentially obtaining ratification of the claim-generation process that Judge Jack condemned. Here too, the worm appears to be turning. In a series of decisions, the Third Circuit Court of Appeals, echoing the exact words I used to describe the ongoing Congoleum bankruptcy proceeding, stated that to approve a reorganization plan tainted by lawyers' engaging in conflicts of interest and securing preferential treatment for their clients in order to generate additional fees, "would be a perversion of the bankruptcy process."

 

The next shoe to drop may be in federal court in New York. If indictments are forthcoming-and lawyers who sponsored the mass screenings and collected billions of dollars in fees are among those indicted-the ensuing process could shine a floodlight on a fraudulent scheme so massive as to qualify nonmalignant asbestos litigation for entry into the pantheon of such great American frauds as Enron, WorldCom, OPM, Credit Mobilier and Teapot Dome.

 

Despite having written volumes on asbestos litigation, the legal academy has reacted to the mounting evidence of pervasive fraud with a crescendo of silence. This may be explained by the fact that most tort scholars share common interests with tort lawyers. Tort lawyers benefit from and ratify the validity of tort scholars’ theories for expanding the scope of liability in the tort system by uncovering examples of egregious corporate conduct. Moreover, tort lawyers, one of the largest single-issue contributors to political campaigns, account for a substantial portion of the Democratic Party’s funding. Without their share of the profits from tort suits, the Democratic Party’s ability to advance policies and positions that many torts scholars espouse could be in jeopardy. It is this political dimension of the tort system that may account for the silence of the legal academy in the face of evidence of a massive civil justice system failure.

 

Columnist:

   

Professor Lester Brickman

Cardozo School of Law

55 Fifth Avenue

New York, N.Y. 10003

212 790 0327

212 790 0205 (fax)

brickman@yu.edu

 

 

 


 

 

Op-Ed article submissions should be made to Op-Ed@lawexec.com. All articles must include contact information for the author(s) and only signed articles will be considered for publication.

 

 

If you know of or have authored an article or report that deserves recognition among corporate and public policy leaders, please send an email to LegalReform@lawexec.com.  Original material © 2005 American Justice Partnership.